Published in J Transl Med on January 30, 2007
Sleep, HIV Disease Progression, and Function in HIV Infected Children and Adolescents | NCT00253695
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis (2003) 8.00
Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med (1995) 6.50
CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.45
Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells. Immunity (2001) 2.37
Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J Gen Virol (2003) 2.23
In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. J Clin Invest (2005) 1.96
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. J Clin Invest (2005) 1.82
IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation. Blood (2004) 1.82
Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med (1997) 1.63
CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients. AIDS (2001) 1.21
Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response. J Infect Dis (2004) 1.21
Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. Cell Death Differ (1999) 1.19
Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3: CPCRA 059. J Acquir Immune Defic Syndr (2002) 1.13
CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway. Blood (2000) 1.06
Persistent apoptosis in HIV-1-infected individuals receiving potent antiretroviral therapy is associated with poor recovery of CD4 T lymphocytes. J Acquir Immune Defic Syndr (2004) 0.95
Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART. Clin Immunol (2000) 0.94
T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: impact of highly active antiretroviral therapy. Clin Immunol (2001) 0.93
Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors. AIDS Res Hum Retroviruses (2002) 0.93
Nadir CD4+ T cell count predicts response to subcutaneous recombinant interleukin-2. Clin Infect Dis (2003) 0.90
Discordant CD4 T lymphocyte responses to antiretroviral therapy for HIV infection are associated with ex-vivo rates of apoptosis. AIDS (2001) 0.89
Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4+ and CD8+ lymphocyte apoptosis in HIV+ patients. Clin Exp Immunol (2000) 0.87
Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics. AIDS (2004) 0.86
Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients. AIDS (2004) 0.85
Lack of control of T cell apoptosis under HAART. Influence of therapy regimen in vivo and in vitro. AIDS (2002) 0.85
Partial immune reconstitution following highly active antiretroviral therapy: can adjuvant interleukin-2 fill the gap? J Antimicrob Chemother (2005) 0.85
Costimulatory pathways mediate monocyte-dependent lymphocyte apoptosis in HIV. Clin Immunol (1999) 0.84
CXCR4-mediated T cell apoptosis in human immunodeficiency virus infection. J Gen Virol (2004) 0.84
Inverse correlation between CD8+ lymphocyte apoptosis and CD4+ cell counts during potent antiretroviral therapy in HIV patients. J Antimicrob Chemother (2004) 0.80
Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects. Clin Diagn Lab Immunol (2001) 0.79
Acute activation of CD8+ T lymphocytes in interleukin-2-treated HIV-infected patients. ANRS-048 IL-2 Study Group. Agence Nationale de Recherches sur le SIDA. J Acquir Immune Defic Syndr (1999) 0.78
Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer (2008) 4.47
A randomized clinical trial comparing oral ondansetron with placebo in children with vomiting from acute gastroenteritis. Ann Emerg Med (2002) 3.37
Association between simian virus 40 and non-Hodgkin lymphoma. Lancet (2002) 2.99
The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults. AIDS Res Hum Retroviruses (2002) 2.89
A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS (2006) 2.77
Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr (2003) 2.33
Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res (2004) 2.17
A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy. AIDS (2003) 1.99
Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine (2005) 1.97
Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. J Infect Dis (2010) 1.86
Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome. J Natl Cancer Inst (2003) 1.83
Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res (2011) 1.51
Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics (2007) 1.28
Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatr Blood Cancer (2011) 1.28
Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. Arch Pediatr Adolesc Med (2004) 1.23
Impact of a cell phone intervention on mediating mechanisms of smoking cessation in individuals living with HIV/AIDS. Nicotine Tob Res (2006) 1.21
Lipodystrophy syndrome in human immunodeficiency virus-infected children. Pediatr Infect Dis J (2002) 1.16
Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates. Infect Control Hosp Epidemiol (2014) 1.12
Assessing a conceptual framework of health-related quality of life in a HIV/AIDS population. Qual Life Res (2005) 1.11
LDH concentration in nasal-wash fluid as a biochemical predictor of bronchiolitis severity. Pediatrics (2010) 1.10
Radiographic abnormalities in Rothmund-Thomson syndrome and genotype-phenotype correlation with RECQL4 mutation status. AJR Am J Roentgenol (2008) 1.10
Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS. Clin Infect Dis (2003) 1.09
Simian virus 40 in human cancers. Am J Med (2003) 1.06
The effect of treatment on pathogen virulence. J Theor Biol (2004) 1.06
Internet use in families with children requiring cardiac surgery for congenital heart disease. Pediatrics (2002) 1.05
The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS. AIDS Patient Care STDS (2007) 1.05
Fosamprenavir calcium plus ritonavir for HIV infection. Expert Rev Anti Infect Ther (2007) 1.04
Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome. J Clin Oncol (2007) 1.03
Neural tube defects: knowledge and preconceptional prevention practices in minority young women. Pediatrics (2003) 1.02
Prevalence of asthma in children and young adults with HIV infection. J Allergy Clin Immunol (2007) 1.02
Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS. Clin Infect Dis (2013) 0.99
Improvement in provider immunization knowledge and behaviors following a peer education intervention. Clin Pediatr (Phila) (2007) 0.99
Invasive mechanical ventilation for acute respiratory failure in children with cystic fibrosis: outcome analysis and case-control study. Pediatr Pulmonol (2002) 0.97
Human adipose tissue as a reservoir for memory CD4+ T cells and HIV. AIDS (2015) 0.95
Integration of human immunodeficiency virus type 1 in untreated infection occurs preferentially within genes. J Virol (2006) 0.95
Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care STDS (2012) 0.95
Correlates of consistent condom use with main-new and main-old sexual partners. J Adolesc Health (2009) 0.93
Lymphotropism of Merkel cell polyomavirus infection, Nova Scotia, Canada. Emerg Infect Dis (2010) 0.93
High prevalence of hepatitis B virus markers in Romanian adolescents with human immunodeficiency virus infection. MedGenMed (2005) 0.93
Toscana meningoencephalitis: a comparison to other viral central nervous system infections. J Clin Virol (2012) 0.91
Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX. J Clin Virol (2009) 0.90
A phase II trial using thalidomide for Langerhans cell histiocytosis. Pediatr Blood Cancer (2007) 0.89
Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS (2003) 0.88
Functional status and overall quality of life in a multiethnic HIV-positive population. AIDS Patient Care STDS (2003) 0.87
Cervical cancer screening adherence among HIV-positive female smokers from a comprehensive HIV clinic. AIDS Behav (2014) 0.86
The association between body image and smoking cessation among individuals living with HIV/AIDS. Body Image (2007) 0.86
High prevalence of hepatitis B virus markers in romanian adolescents with human immunodeficiency virus infection. J Int AIDS Soc (2005) 0.86
Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS-related systemic non-Hodgkin lymphoma. J Acquir Immune Defic Syndr (2002) 0.85
A decrease in drug resistance levels of the HIV epidemic can be bad news. Bull Math Biol (2004) 0.85
Granzyme B secretion by human memory CD4 T cells is less strictly regulated compared to memory CD8 T cells. BMC Immunol (2014) 0.84
Granzyme B- and Fas ligand-mediated cytotoxic function induced by mitogenic CD28 stimulation of human memory CD4+ T cells. J Leukoc Biol (2012) 0.84
Utilizing peer academic detailing to improve childhood immunization coverage levels. Health Promot Pract (2008) 0.84
Conventional epidemiology and the link between SV40 and human cancers. Lancet Oncol (2003) 0.84
Magnitude of IFN-gamma production in HIV-1-infected children is associated with virus suppression. J Allergy Clin Immunol (2002) 0.83
Successful techniques for retaining a cohort of infants and children born to HIV-infected women: the prospective P2C2 HIV study. J Assoc Nurses AIDS Care (2004) 0.83
Teaching testicular self-examination: education and practices in pediatric residents. Pediatrics (2003) 0.82
AIDS-related systemic non-Hodgkin's lymphoma at a large community program. AIDS Res Hum Retroviruses (2002) 0.81
A nonneutralizing anti-HIV Type 1 antibody turns into a broad neutralizing antibody when expressed on the surface of HIV type 1-susceptible cells. II. Inhibition of HIV type 1 captured and transferred by DC-SIGN. AIDS Res Hum Retroviruses (2006) 0.81
Absence of XMRV in peripheral blood mononuclear cells of ARV-treatment naïve HIV-1 infected and HIV-1/HCV coinfected individuals and blood donors. PLoS One (2012) 0.80
Efficacy of a motivational behavioral intervention to promote chlamydia and gonorrhea screening in young women: a randomized controlled trial. J Adolesc Health (2009) 0.79
Perceptions of barriers and facilitators to cervical cancer screening among low-income, HIV-infected women from an integrated HIV clinic. AIDS Care (2014) 0.79
The effect of obesity on the ED(95) of propofol for loss of consciousness in children and adolescents. Anesth Analg (2012) 0.79
Myelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia. Pediatr Blood Cancer (2011) 0.79
Use of fosamprenavir, a sulfa-containing protease inhibitor, in HIV-infected patients with glucose-6-phosphate dehydrogenase deficiency. Clin Infect Dis (2007) 0.78
The influence of HIV disease events/stages on smoking attitudes and behaviors: project STATE (Study of Tobacco Attitudes and Teachable Events). BMC Public Health (2014) 0.77
Dendritic cell-mediated HIV-1 infection of T cells demonstrates a direct relationship to plasma viral RNA levels. J Acquir Immune Defic Syndr (2010) 0.77
Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy. Am J Gastroenterol (2007) 0.76
Genotypic HIV-1 drug resistance testing in antiretroviral-naive subjects in Houston, Texas. J Acquir Immune Defic Syndr (2002) 0.76
Effects of route of inoculation and viral genetic variation on antibody responses to polyomavirus SV40 in Syrian golden hamsters. Comp Med (2012) 0.76
Randomized trial to evaluate nutritional status and absorption of enteral feeding after brain death. Prog Transplant (2013) 0.75
Association between SV40 and non-Hodgkin's lymphoma. Leuk Lymphoma (2003) 0.75
Investigation of obstacles to accessing information regarding private medical insurance coverage and physician reimbursement for adolescent vaccination. J Adolesc Health (2008) 0.75
[Detection of acute infection due to legionella pneumophila in patient with community acquired pneumonia in Buenos Aires city]. Medicina (B Aires) (2002) 0.75
Alopecia associated with ritonavir-boosted atazanavir therapy. AIDS (2007) 0.75
An effective, low-cost approach to implementing HIV/AIDS education programs in low literacy populations: an example from rural Haiti. J Health Care Poor Underserved (2010) 0.75